ATE374824T1 - Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davon - Google Patents
Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davonInfo
- Publication number
- ATE374824T1 ATE374824T1 AT03775599T AT03775599T ATE374824T1 AT E374824 T1 ATE374824 T1 AT E374824T1 AT 03775599 T AT03775599 T AT 03775599T AT 03775599 T AT03775599 T AT 03775599T AT E374824 T1 ATE374824 T1 AT E374824T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- gamma secretase
- based substrates
- notch based
- Prior art date
Links
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 3
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000758 substrate Substances 0.000 title abstract 2
- 241001195348 Nusa Species 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42920602P | 2002-11-26 | 2002-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE374824T1 true ATE374824T1 (de) | 2007-10-15 |
Family
ID=32393521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03775599T ATE374824T1 (de) | 2002-11-26 | 2003-11-17 | Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davon |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110098227A1 (de) |
| EP (1) | EP1567647B1 (de) |
| JP (1) | JP2006508653A (de) |
| KR (1) | KR20050085177A (de) |
| CN (1) | CN1717485A (de) |
| AT (1) | ATE374824T1 (de) |
| AU (1) | AU2003283619A1 (de) |
| CA (1) | CA2505764A1 (de) |
| DE (1) | DE60316718T2 (de) |
| ES (1) | ES2293047T3 (de) |
| HR (1) | HRP20050461A2 (de) |
| NO (1) | NO20052552L (de) |
| RU (1) | RU2005115973A (de) |
| WO (1) | WO2004048578A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0518232D0 (en) * | 2005-09-07 | 2005-10-19 | Merck Sharp & Dohme | New methods |
| US7910324B2 (en) | 2007-06-08 | 2011-03-22 | Eisai R&D Management Co., Ltd. | Method of screening for compounds which affect the processing of EphA4 by γ-secretase |
| JP5580598B2 (ja) | 2007-11-15 | 2014-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | γ−セクレターゼの新規基質ＥｐｈＡ７を利用したスクリーニング方法 |
| US9023767B2 (en) * | 2009-05-07 | 2015-05-05 | Memorial Sloan-Kettering Cancer Center | γ-Secretase substrates and methods of use |
| CN103502466A (zh) * | 2010-09-07 | 2014-01-08 | 斯隆－凯特林纪念癌症中心 | 用于γ-分泌酶测定的方法和组合物 |
| JP6059017B2 (ja) | 2010-12-17 | 2017-01-11 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラチナーゼによるＥｐｈＡ４の切断反応を指標としたスクリーニング方法 |
| JP5961608B2 (ja) | 2011-04-25 | 2016-08-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ＥｐｈＡ４細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法 |
| AR119303A1 (es) | 2019-07-01 | 2021-12-09 | Eisai R&D Man Co Ltd | Anticuerpo anti-epha4 humano |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1257633A1 (de) * | 2000-02-25 | 2002-11-20 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Presenilin defizient |
-
2003
- 2003-11-07 HR HR20050461A patent/HRP20050461A2/hr not_active Application Discontinuation
- 2003-11-17 JP JP2004554808A patent/JP2006508653A/ja active Pending
- 2003-11-17 CN CNA2003801042336A patent/CN1717485A/zh active Pending
- 2003-11-17 ES ES03775599T patent/ES2293047T3/es not_active Expired - Lifetime
- 2003-11-17 DE DE60316718T patent/DE60316718T2/de not_active Expired - Fee Related
- 2003-11-17 CA CA002505764A patent/CA2505764A1/en not_active Abandoned
- 2003-11-17 KR KR1020057009579A patent/KR20050085177A/ko not_active Abandoned
- 2003-11-17 AT AT03775599T patent/ATE374824T1/de not_active IP Right Cessation
- 2003-11-17 EP EP03775599A patent/EP1567647B1/de not_active Expired - Lifetime
- 2003-11-17 RU RU2005115973/13A patent/RU2005115973A/ru not_active Application Discontinuation
- 2003-11-17 AU AU2003283619A patent/AU2003283619A1/en not_active Abandoned
- 2003-11-17 WO PCT/IB2003/005233 patent/WO2004048578A1/en not_active Ceased
- 2003-11-19 US US10/717,244 patent/US20110098227A1/en not_active Abandoned
-
2005
- 2005-05-26 NO NO20052552A patent/NO20052552L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1567647A1 (de) | 2005-08-31 |
| NO20052552D0 (no) | 2005-05-26 |
| DE60316718T2 (de) | 2008-01-24 |
| JP2006508653A (ja) | 2006-03-16 |
| KR20050085177A (ko) | 2005-08-29 |
| US20110098227A1 (en) | 2011-04-28 |
| WO2004048578A1 (en) | 2004-06-10 |
| HRP20050461A2 (en) | 2005-08-31 |
| EP1567647B1 (de) | 2007-10-03 |
| NO20052552L (no) | 2005-08-25 |
| DE60316718D1 (de) | 2007-11-15 |
| RU2005115973A (ru) | 2005-12-20 |
| AU2003283619A1 (en) | 2004-06-18 |
| CA2505764A1 (en) | 2004-06-10 |
| CN1717485A (zh) | 2006-01-04 |
| ES2293047T3 (es) | 2008-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325892D1 (de) | Stellungs- und verwendungsverfahren | |
| ATE457355T1 (de) | Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute | |
| DK1144607T3 (da) | Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger | |
| WO2004099231A3 (en) | Glycopegylation methods and proteins/peptides produced by the methods | |
| DK1346034T3 (da) | von Willebrand-faktor (vWF) spaltende protease-polypeptid, nukleinsyre kodende for polypeptidet og anvendelse af polypeptidet | |
| ATE227739T1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
| ATE482716T1 (de) | Zusammensetzungen basierend auf apo2-ligand/ trail und ihre verwendung | |
| CY1105772T1 (el) | Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια | |
| ATE469913T1 (de) | Antagonisten des nogo-rezeptors | |
| IL217489A (en) | U-pa polypeptides with specific substrate activity or activity and preparations and uses based on these polypeptides | |
| BRPI0414593A (pt) | derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1 | |
| ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
| ATE346168T1 (de) | Funktionelles oberflächendisplay von polypeptiden | |
| AU2003275612A1 (en) | Defructosylation method | |
| WO2003104282A8 (en) | Glycoprotein vi - fc fusion protein for treating vascular disorders | |
| DE60134230D1 (de) | Substraten und nachweise zur wirksamkeit von beta-secretase | |
| ATE374824T1 (de) | Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davon | |
| MXPA04001730A (es) | Metodo para determinacion de multiples analitos. | |
| DK1485481T3 (da) | Fflourescerende protein fra Aequorea Coerulescens og anvendelser deraf | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| DK1066328T3 (da) | Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion | |
| ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
| DE60326048D1 (de) | Kristallstruktur des angiotensin-konvertierenden enzyms (ace) und ihre verwendung | |
| AR015513A1 (es) | Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf | |
| GB0220199D0 (en) | Mutant protein and refolding method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |